Artesunate

(Artesunate®)

Artesunate

Drug updated on 11/14/2023

Dosage FormInjection (intravenous; 110 mg of artesunate as a powder in a single-dose vial for constitution with the supplied sterile diluent)
Drug ClassAntimalarials
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the initial treatment of severe malaria in adult and pediatric patients.
  • For the treatment of severe malaria. Treatment of severe malaria with Artesunate for Injection should always be followed by a complete treatment course of an appropriate oral antimalarial regimen.

Product Monograph / Prescribing Information

Document TitleYearSource
Artesunate (Artesunate) Prescribing Information.2021Amivas LLC, Wilmington Delaware

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines

Document TitleYearSource
Review of UK malaria treatment guidelines 2016 (Public Health England Advisory Committee on Malaria Prevention).2018Archives of Disease in Childhood: Education & Practice